Floatz logo

Eloxatin

LDRT

Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityPhase 1/2Active
CCC
50/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
40/ 100
Competitive Position
81/ 100

Competitive context

9 Active assets in the LDRT cohort.

Asset / SponsorPhaseRating
Calcium folinate pentahydrate
Zhejiang Provincial People's Hospital
Phase 1/2CC
Pucotenlimab
Zhejiang Provincial People's Hospital
Phase 1/2CC
FLUOROURACILUM
Zhejiang Provincial People's Hospital
Phase 1/2CC
Irinotecan
Zhejiang Provincial People's Hospital
Phase 1/2CC
Tislelizumab
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Phase 1CC

View all 9 →

Same molecule, other indications

Eloxatin is also rated in:

exocrine pancreatic carcinomaDormant
BBB
Indicative ·
78 / 100
View asset →
colon adenocarcinomaDormant
BBB
Indicative ·
77 / 100
View asset →
colorectal neoplasmDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →